Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Arrhythmias

  Free Subscription


22.10.2018

1 Am J Cardiol
1 Ann Thorac Surg
3 Clin Cardiol
2 Eur Heart J
2 Heart
5 Int J Cardiol
1 J Cardiol
1 J Electrocardiol
7 J Interv Card Electrophysiol
1 J Thorac Cardiovasc Surg
2 Pacing Clin Electrophysiol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Cardiol

  1. GUEDENEY P, Chieffo A, Snyder C, Mehilli J, et al
    Impact of Baseline Atrial Fibrillation on Outcomes Among Women Who Underwent Contemporary Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry).
    Am J Cardiol. 2018 Sep 8. pii: S0002-9149(18)31735.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  2. JU MH, Huh JH, Lee CH, Kim HJ, et al
    Robotic-Assisted Surgical Ablation of Atrial Fibrillation Combined with Mitral Valve Surgery.
    Ann Thorac Surg. 2018 Oct 11. pii: S0003-4975(18)31468.
    PubMed     Text format     Abstract available


    Clin Cardiol

  3. DOSHI R, Decter DH, Meraj P
    Prevalence of Arrhythmias and Impact of Permanent Pacemaker Implantation in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Clin Cardiol. 2018 Mar 13. doi: 10.1002/clc.22943.
    PubMed     Text format     Abstract available

  4. RAVI V, Iskander F, Saini A, Brecklin C, et al
    Clinical predictors and outcomes of patients with pericardial effusion in chronic kidney disease.
    Clin Cardiol. 2018;41:660-665.
    PubMed     Text format     Abstract available

  5. PRASITLUMKUM N, Kanitsoraphan C, Kittipibul V, Rattanawong P, et al
    Baseline Atrial Fibrillation Is Associated With Contrast-Induced Nephropathy After Cardiac Catheterization In Coronary Artery Disease: Systemic Review And Meta-Analysis.
    Clin Cardiol. 2018 Oct 17. doi: 10.1002/clc.23100.
    PubMed     Text format     Abstract available


    Eur Heart J

  6. ZAFRIR B, Lund LH, Laroche C, Ruschitzka F, et al
    Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry.
    Eur Heart J. 2018 Oct 15. pii: 5133012. doi: 10.1093.
    PubMed     Text format     Abstract available

  7. JOHN RM, Michaud GF, Stevenson WG
    Atrial fibrillation hospitalization, mortality, and therapy.
    Eur Heart J. 2018 Oct 16. pii: 5133619. doi: 10.1093.
    PubMed     Text format    


    Heart

  8. BERNTSSON J, Smith JG, Johnson LSB, Soderholm M, et al
    Increased vascular endothelial growth factor D is associated with atrial fibrillation and ischaemic stroke.
    Heart. 2018 Oct 16. pii: heartjnl-2018-313684. doi: 10.1136/heartjnl-2018-313684
    PubMed     Text format     Abstract available

  9. HIJAZI Z, Wallentin L
    Natriuretic peptide should be used as a routine tool for evaluation of patients with atrial fibrillation.
    Heart. 2018 Oct 12. pii: heartjnl-2018-314040. doi: 10.1136/heartjnl-2018-314040
    PubMed     Text format    


    Int J Cardiol

  10. SCOTT L JR, Li N, Dobrev D
    Role of inflammatory signaling in atrial fibrillation.
    Int J Cardiol. 2018 Oct 4. pii: S0167-5273(18)35864.
    PubMed     Text format     Abstract available

  11. SLUYTER JD, Camargo CA Jr, Lowe A, Scragg RKR, et al
    Pulse rate variability predicts atrial fibrillation and cerebrovascular events in a large, population-based cohort.
    Int J Cardiol. 2018 Oct 10. pii: S0167-5273(18)34448.
    PubMed     Text format     Abstract available

  12. RUSSO V, Solimene F, Zanotto G, Pisano EC, et al
    Seasonal trend of ventricular arrhythmias in a nationwide remote monitoring database of implantable defibrillators and cardiac resynchronization devices.
    Int J Cardiol. 2018 Oct 10. pii: S0167-5273(18)35326.
    PubMed     Text format     Abstract available

  13. WANG S, Su Z, Zhang Y
    The true prevalence of inappropriate anticoagulation therapy in Chinese patients with a CHA2DS2-VASc score of 0.
    Int J Cardiol. 2018;266:159.
    PubMed     Text format    

  14. CHEN HL, Cai JY, Zha ML, Liu K, et al
    Does CHA2DS2-VASc score have the discrimination and calibration power in predicting renal function decline?
    Int J Cardiol. 2018;266:161.
    PubMed     Text format    


    J Cardiol

  15. ISO K, Watanabe I, Okumura Y, Nagashima K, et al
    No association between dormant conduction sites and pulmonary vein reconnection sites in late atrial fibrillation recurrence after catheter ablation.
    J Cardiol. 2018;72:488-493.
    PubMed     Text format     Abstract available


    J Electrocardiol

  16. FILGUEIRAS-RAMA D, Lillo-Castellano JM, Quintanilla JG
    Ventricular fibrillation undersensing to calculate a safety threshold for baseline rhythm R-wave amplitudes.
    J Electrocardiol. 2018 Oct 9. pii: S0022-0736(18)30629.
    PubMed     Text format    


    J Interv Card Electrophysiol

  17. FU G, He B, Wang B, Liu J, et al
    Unipolar electrogram-guided radiofrequency catheter ablation in paroxysmal atrial fibrillation: electrogram patterns and outcomes.
    J Interv Card Electrophysiol. 2018 Oct 17. pii: 10.1007/s10840-018-0470.
    PubMed     Text format     Abstract available

  18. NOSEWORTHY PA, Brito JP, Kunneman M, Hargraves IG, et al
    Shared decision-making in atrial fibrillation: navigating complex issues in partnership with the patient.
    J Interv Card Electrophysiol. 2018 Oct 17. pii: 10.1007/s10840-018-0465.
    PubMed     Text format     Abstract available

  19. GUHL EN, Smith B, Lehmann H, Adelstein E, et al
    Improvement in ejection fraction after cryoballoon pulmonary vein isolation for atrial fibrillation in individuals with systolic dysfunction.
    J Interv Card Electrophysiol. 2018 Oct 17. pii: 10.1007/s10840-018-0475.
    PubMed     Text format     Abstract available

  20. MAZZONE P, D'Angelo G, Regazzoli D, Molon G, et al
    Percutaneous Left Atrial Appendage Closure with WATCHMAN device: peri-procedural and mid-term outcomes from the TRAPS Registry.
    J Interv Card Electrophysiol. 2018;52:47-52.
    PubMed     Text format     Abstract available

  21. LEONG D, Sovari AA, Ehdaie A, Chakravarty T, et al
    Permanent-temporary pacemakers in the management of patients with conduction abnormalities after transcatheter aortic valve replacement.
    J Interv Card Electrophysiol. 2018;52:111-116.
    PubMed     Text format     Abstract available

  22. LI Y, Xue Y, Yu J, Jiang C, et al
    Electrophysiological characteristics and radiofrequency ablation of sustained monomorphic ventricular tachycardia in adult patients with isolated ventricular noncompaction.
    J Interv Card Electrophysiol. 2018;52:117-125.
    PubMed     Text format     Abstract available

  23. LIANG Z, Ren X, Zhang T, Han Z, et al
    Mapping and ablation of RVOT-type arrhythmias: comparison between the conventional and reversed U curve methods.
    J Interv Card Electrophysiol. 2018;52:19-30.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  24. SUWALSKI P, Kowalewski M, Jasinski M, Staromlynski J, et al
    Survival after surgical ablation for atrial fibrillation in mitral valve surgery: Analysis from the Polish National Registry of Cardiac Surgery Procedures (KROK).
    J Thorac Cardiovasc Surg. 2018 Sep 8. pii: S0022-5223(18)32321.
    PubMed     Text format     Abstract available


    Pacing Clin Electrophysiol

  25. SINGH B, Zhang S, Ching CK, Huang D, et al
    Improving the utilization of implantable cardioverter defibrillators for sudden cardiac arrest prevention (improve SCA) in developing countries: Clinical characteristics and reasons for implantation refusal.
    Pacing Clin Electrophysiol. 2018 Oct 15. doi: 10.1111/pace.13526.
    PubMed     Text format     Abstract available

  26. LAU CP, Hai JJ, Siu CW
    Implantable cardioverter defibrillators in Asia.
    Pacing Clin Electrophysiol. 2018 Oct 15. doi: 10.1111/pace.13525.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: